Pharmaceutical / Drug Definition :
Inhibits osteoclast-mediated bone resorption. Also exerts antiresorptive effect, probably by directly inhibiting mature osteoclast activity or indirectly inhibiting osteoblasts
FDA Label Requirements and Exceptions
Risedronate Sodium
FDA Import Information
Risedronate Sodium
FDA Detentions
Risedronate Sodium (Risedronate Sodium Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Risedronate Sodium (Risedronate Sodium Suppliers)
- Processors Risedronate Sodium
- Repackers Risedronate Sodium
- Relabelers Risedronate Sodium
- Exporters Risedronate Sodium
- Importers Risedronate Sodium
For more information about Risedronate Sodium, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.
